81 related articles for article (PubMed ID: 17452776)
1. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
Tommasi S; Fedele V; Lacalamita R; Bruno M; Schittulli F; Ginzinger D; Scott G; Eppenberger-Castori S; Calistri D; Casadei S; Seymour I; Longo S; Giannelli G; Pilato B; Simone G; Benz CC; Paradiso A
Cell Oncol; 2007; 29(3):241-8. PubMed ID: 17452776
[TBL] [Abstract][Full Text] [Related]
2. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
Frank B; Hemminki K; Wirtenberger M; Bermejo JL; Bugert P; Klaes R; Schmutzler RK; Wappenschmidt B; Bartram CR; Burwinkel B
Carcinogenesis; 2005 Mar; 26(3):643-7. PubMed ID: 15550452
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
[TBL] [Abstract][Full Text] [Related]
4. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Adem C; Soderberg CL; Hafner K; Reynolds C; Slezak JM; Sinclair CS; Sellers TA; Schaid DJ; Couch F; Hartmann LC; Jenkins RB
Genes Chromosomes Cancer; 2004 Sep; 41(1):1-11. PubMed ID: 15236312
[TBL] [Abstract][Full Text] [Related]
5. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Antoniou AC; Wang X; Fredericksen ZS; McGuffog L; Tarrell R; Sinilnikova OM; Healey S; Morrison J; Kartsonaki C; Lesnick T; Ghoussaini M; Barrowdale D; ; Peock S; Cook M; Oliver C; Frost D; Eccles D; Evans DG; Eeles R; Izatt L; Chu C; Douglas F; Paterson J; Stoppa-Lyonnet D; Houdayer C; Mazoyer S; Giraud S; Lasset C; Remenieras A; Caron O; Hardouin A; Berthet P; ; Hogervorst FB; Rookus MA; Jager A; van den Ouweland A; Hoogerbrugge N; van der Luijt RB; Meijers-Heijboer H; Gómez García EB; ; Devilee P; Vreeswijk MP; Lubinski J; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Górski B; Cybulski C; Spurdle AB; Holland H; ; Goldgar DE; John EM; Hopper JL; Southey M; Buys SS; Daly MB; Terry MB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Preisler-Adams S; Arnold N; Niederacher D; Sutter C; Domchek SM; Nathanson KL; Rebbeck T; Blum JL; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Blank SV; Friedman E; Kaufman B; Laitman Y; Milgrom R; Andrulis IL; Glendon G; Ozcelik H; Kirchhoff T; Vijai J; Gaudet MM; Altshuler D; Guiducci C; ; Loman N; Harbst K; Rantala J; Ehrencrona H; Gerdes AM; Thomassen M; Sunde L; Peterlongo P; Manoukian S; Bonanni B; Viel A; Radice P; Caldes T; de la Hoya M; Singer CF; Fink-Retter A; Greene MH; Mai PL; Loud JT; Guidugli L; Lindor NM; Hansen TV; Nielsen FC; Blanco I; Lazaro C; Garber J; Ramus SJ; Gayther SA; Phelan C; Narod S; Szabo CI; ; Benitez J; Osorio A; Nevanlinna H; Heikkinen T; Caligo MA; Beattie MS; Hamann U; Godwin AK; Montagna M; Casella C; Neuhausen SL; Karlan BY; Tung N; Toland AE; Weitzel J; Olopade O; Simard J; Soucy P; Rubinstein WS; Arason A; Rennert G; Martin NG; Montgomery GW; Chang-Claude J; Flesch-Janys D; Brauch H; ; Severi G; Baglietto L; Cox A; Cross SS; Miron P; Gerty SM; Tapper W; Yannoukakos D; Fountzilas G; Fasching PA; Beckmann MW; Dos Santos Silva I; Peto J; Lambrechts D; Paridaens R; Rüdiger T; Försti A; Winqvist R; Pylkäs K; Diasio RB; Lee AM; Eckel-Passow J; Vachon C; Blows F; Driver K; Dunning A; Pharoah PP; Offit K; Pankratz VS; Hakonarson H; Chenevix-Trench G; Easton DF; Couch FJ
Nat Genet; 2010 Oct; 42(10):885-92. PubMed ID: 20852631
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
7. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer.
Gutiérrez Povedano C; Salgado J; Gil C; Robles M; Patiño-García A; García-Foncillas J
Mitochondrial DNA; 2015 Apr; 26(2):227-31. PubMed ID: 23984822
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of BRCA1 Polymorphisms and Breast Cancer Susceptibility.
Ghafouri-Fard S; Dianatpour A; Faramarzi S
Klin Onkol; 2018; 31(5):330-338. PubMed ID: 30541318
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
Tommasi S; Crapolicchio A; Lacalamita R; Bruno M; Monaco A; Petroni S; Schittulli F; Longo S; Digennaro M; Calistri D; Mangia A; Paradiso A
Mutat Res; 2005 Oct; 578(1-2):395-405. PubMed ID: 16026807
[TBL] [Abstract][Full Text] [Related]
10. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
11. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer.
Jamard E; Volard B; Dugué AE; Legros A; Leconte A; Clarisse B; Davy G; Polycarpe F; Dugast C; Abadie C; Frebourg T; Tinat J; Tennevet I; Layet V; Joly F; Castéra L; Berthet P; Vaur D; Krieger S
Fam Cancer; 2017 Apr; 16(2):167-171. PubMed ID: 27783335
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.
Cresti N; Lee J; Rourke E; Televantou D; Jamieson D; Verrill M; Boddy AV
Eur J Cancer; 2016 Mar; 55():27-37. PubMed ID: 26773371
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
[TBL] [Abstract][Full Text] [Related]
16. Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence.
Medimegh I; Troudi W; Stambouli N; Khodjet-El-Khil H; Baroudi O; Ayari H; Omrane I; Uhrhammer N; Privat M; Mezlini A; Ayed FB; Romdhane KB; Mader S; Bignon YJ; Elgaaied AB
Med Oncol; 2014 Nov; 31(11):255. PubMed ID: 25273865
[TBL] [Abstract][Full Text] [Related]
17. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
[TBL] [Abstract][Full Text] [Related]
19. Differential Gene Expression of BRCA1,ERBB2 and TP53 biomarkers between Human Breast Tissue and Peripheral Blood Samples of Breast Cancer.
Zghair AN; Sinha DK; Kassim A; Alfaham M; Sharma AK
Anticancer Agents Med Chem; 2016; 16(4):519-25. PubMed ID: 26299666
[TBL] [Abstract][Full Text] [Related]
20. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
